SC
TEVA icon

Samlyn Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Samlyn Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,954,175
Closed -$105M – 135
2016
Q1 		$105M Buy
1,954,175
+305,662
+19% +$17.9M 2.25% 8
2015
Q4 		$108M Sell
1,648,513
-882,487
-35% -$54.5M 2.24% 14
2015
Q3 		$143M Buy
2,531,000
+398,840
+19% +$25.9M 2.62% 6
2015
Q2 		$126M Buy
2,132,160
+310,760
+17% +$19.2M 2% 11
2015
Q1 		$113M Buy
1,821,400
+123,900
+7% +$7.2M 1.82% 18
2014
Q4 		$97.6M Buy
1,697,500
+630,800
+59% +$35.1M 1.7% 17
2014
Q3 		$57.3M Buy
1,066,700
+296,700
+39% +$15.7M 1.18% 42
2014
Q2 		$40.4M Buy
+770,000
New +$39.4M 0.92% 51

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return